The combination of a new sovereign stake and a high-conviction quant fund doubling down suggests growing confidence in RMD's valuation or upcoming catalysts. Traders should monitor for follow-on buying and any shifts in Fidelity's positioning in the next quarter.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $256.94entry
- T+1 · 9mo ago +0.32%α +1.23% · $257.75
- T+5 · 8mo ago −1.90%α −0.69% · $252.06
- T+20 · 8mo ago −14.38%α −6.44% · $220.00
- T+60 · 6mo ago −19.05%α −28.38% · $207.98
How similar events traded
Executive Summary
Three major institutions, Morgan Stanley, Norges Bank, and RenTech, collectively added $369.9M in new positions in ResMed Inc (RMD) during 2025-Q4, signaling strong institutional conviction. This buying was partially offset by Fidelity trimming its stake by over half, reducing its position by $140.8M. The cluster reflects diverging views, but with notable new commitments from a sovereign wealth fund and a high-conviction double from a quant fund.
Key Financial Metrics
Institutional Positions
Net institutional flow: $229.1M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +25% | $696.5M | $63.3M |
| Norges Bank | NEW | +0% | $249.1M | $249.1M |
| RenTech | DOUBLED | +425% | $73.3M | $57.5M |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Fidelity | TRIM | 52.8% | $241.0M | -$140.8M |
Key Facts
- Morgan Stanley increased its stake by 25%, adding 578.6K shares with a value gain of $63.3M.
- Norges Bank established a new $249.1M position, indicating fresh sovereign interest in RMD.
- RenTech more than quadrupled its holdings (up 425%), doubling down with a $57.5M increase in value.
- Fidelity trimmed its position by 52.8%, exiting $140.8M in value, the only bearish signal in the cluster.
Financial Impact
Net institutional accumulation of $229.1M ($369.9M in buys, $140.8M in sells), representing meaningful capital reallocation into RMD.
Risk Factors
- Fidelity's significant trim may reflect concerns about valuation or sector headwinds in sleep apnea devices.
- Morgan Stanley and Fidelity are both mega-passives, so their actions may reflect index flows rather than fundamental views.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-RMD-2025-Q4 |
Track record
19 reports on RMD
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 settles Dec 9
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 ▲ +0.29% −3.17% vs SPY
- Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 ▲ +6.08% +11.37% vs SPY
- Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 ▲ +5.05% +6.86% vs SPY
- Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 ▲ +15.51% +17.31% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 No price data
- Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 ▲ +3.26% +1.13% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 ▼ −2.17% −1.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers